Savara Inc (SVRA)
4.68
-0.03
(-0.64%)
USD |
NASDAQ |
Apr 23, 16:00
4.68
0.00 (0.00%)
After-Hours: 20:00
Savara Free Cash Flow: -51.36M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -51.36M |
| September 30, 2023 | -44.38M |
| June 30, 2023 | -39.34M |
| March 31, 2023 | -38.17M |
| December 31, 2022 | -34.56M |
| September 30, 2022 | -35.32M |
| June 30, 2022 | -36.09M |
| March 31, 2022 | -38.97M |
| December 31, 2021 | -40.14M |
| September 30, 2021 | -43.04M |
| June 30, 2021 | -40.82M |
| March 31, 2021 | -36.40M |
| December 31, 2020 | -43.13M |
| September 30, 2020 | -40.78M |
| June 30, 2020 | -45.48M |
| March 31, 2020 | -50.65M |
| December 31, 2019 | -45.27M |
| September 30, 2019 | -45.87M |
| June 30, 2019 | -43.23M |
| March 31, 2019 | -40.68M |
| December 31, 2018 | -39.42M |
| September 30, 2018 | -38.77M |
| June 30, 2018 | -38.24M |
| March 31, 2018 | -35.52M |
| December 31, 2017 | -28.73M |
| Date | Value |
|---|---|
| September 30, 2017 | -21.02M |
| June 30, 2017 | -15.63M |
| March 31, 2017 | 0.052M |
| December 31, 2016 | -8.378M |
| September 30, 2016 | 13.29M |
| June 30, 2016 | 7.875M |
| March 31, 2016 | -8.692M |
| December 31, 2015 | -4.778M |
| September 30, 2015 | -30.28M |
| June 30, 2015 | -27.39M |
| March 31, 2015 | -25.93M |
| December 31, 2014 | -24.79M |
| September 30, 2014 | -23.63M |
| June 30, 2014 | -22.03M |
| March 31, 2014 | -19.62M |
| December 31, 2013 | -17.84M |
| September 30, 2013 | -16.38M |
| June 30, 2013 | -15.75M |
| March 31, 2013 | -14.03M |
| December 31, 2012 | -14.18M |
| September 30, 2012 | -14.00M |
| June 30, 2012 | -14.49M |
| March 31, 2012 | -16.13M |
| December 31, 2011 | -13.88M |
| September 30, 2011 | -12.01M |
Free Cash Flow Range, Past 5 Years
-51.36M
Minimum
Dec 2023
-34.56M
Maximum
Dec 2022
-41.74M
Average
-40.82M
Median
Jun 2021
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.60M |
| Cash from Investing (Quarterly) | 6.571M |
| Cash from Financing (Quarterly) | 7.895M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow Yield | -6.70% |